Individual decision · SEC · 24 Jul 2015

SEC Division of Corporation Finance no-action letter: Biomet, Inc.

Applies to: A named firm

The Staff of the Division of Corporation Finance concurs that the effectiveness of a post-effective amendment to a Market-Making Registration Statement on Form S-1 during the fiscal year ended May 31, 2015 does not preclude Biomet, Inc. and its 100% owned subsidiaries from filing a Form 15 to suspend their reporting obligations under Section 15(d) of the Securities Exchange Act of 1934. This relief allows the Registrants to suspend the duty to file Annual Reports on Form 10-K for the fiscal year ended May 31, 2015, provided they file the Form 15 on or prior to August 29, 2015. The Staff's agreement is based on the redemption of all outstanding Notes, the absence of record holders for the securities, and the Registrants' compliance with the requirements of Rule 12h-3(a) and (b).

US FederalSecurities and Exchange Commission

Lineage

The documents this one cites, and the documents that cite it.

Securities Act of 19331933 · US-LAWSecurities Act of 1933 (1933-05-27)Securities Exchange Act of 19341934 · US-LAWSecurities Exchange Act of 1934 (1934-06-06)SEC Division of CorporationFinance no-action letter: Bio…2015-07-24 · this documentSEC Division of Corporation Finance no-action letter: Biomet, Inc. (2015-07-24)
amendssupersedesissued underrefers todashed card: not in RegAlert (or proposed)arrows run from the older text to the one that changes it
The links and the sentences they come from (2)
Issued under

More like this from SEC

SEC published 5 documents in the last 30 days. We email you each new one the day it's published.

Source: Securities and Exchange Commission — original document · Summary generated with machine assistance and reviewed before publication; the authoritative text is the regulator's original document. How RegAlert works

In RegAlert: added · updated